# LY6G6F

## Overview
LY6G6F is a gene that encodes the protein lymphocyte antigen 6 family member G6F, which is part of the Ly6/uPAR family. This family is characterized by the presence of LU domains, which are structural motifs involved in various cellular functions. The LY6G6F gene is located on chromosome 6p21 within the human leukocyte antigen (HLA) complex, suggesting its potential involvement in immune responses (Loughner2016Organization; Shiina2009The). The protein encoded by LY6G6F is a type I transmembrane protein and is predicted to lack a GPI-anchor, distinguishing it from other family members that are typically membrane-tethered (Loughner2016Organization). Although the specific functions of LY6G6F remain to be fully elucidated, it is expressed in certain leukemia cells and is implicated in cellular signaling processes, particularly in response to platelet activation (Loughner2016Organization; Shiina2009The). The expression of LY6G6F is most pronounced in blood and testis, indicating a potential role in these tissues (Caruso2022Lymphocyte).

## Structure
LY6G6F is a member of the Ly6/uPAR family, characterized by the presence of a LU domain with a distinctive three-fingered folding topology. This structure is formed by three long loops extending from a disulfide-rich core, which is crucial for the protein's function (Leth2019Evolution). The LU domain typically consists of 60-90 amino acid residues and is stabilized by specific disulfide bonds, although variations in these bonds can lead to functional diversification (Leth2019Evolution).

The gene encoding LY6G6F is located on human chromosome 6p21, within a cluster of related genes, suggesting an evolutionary expansion through gene duplication (Loughner2016Organization; Leth2019Evolution). LY6G6F is expressed in K562 acute myeloblastic leukemia cells and interacts with proteins such as GRB2 and GRB7, although its specific cellular function remains unknown (Loughner2016Organization). It is predicted not to have a GPI-anchor, which is a common feature in many Ly6/uPAR family proteins (Loughner2016Organization).

The LU domain's structure in LY6G6F is similar to that of snake venom neurotoxins, with a conserved disulfide bridge pattern that contributes to its stability and function (Loughner2016Organization). The protein may also undergo post-translational modifications such as glycosylation, which is typical for members of this family.

## Function
LY6G6F is a member of the Ly6/uPAR family, characterized by the presence of LU domains, which are structural motifs involved in various cellular functions. This gene is part of a cluster located in the class III region of the human leukocyte antigen (HLA) complex and encodes a type I transmembrane protein that belongs to the immunoglobulin superfamily. LY6G6F is predicted to lack a GPI-anchor signal, which distinguishes it from other family members that are typically membrane-tethered via a GPI-anchor domain (Loughner2016Organization; Shiina2009The).

The protein encoded by LY6G6F is likely involved in cellular signaling processes, which are crucial for various immune responses. It may play a role in signal transduction, particularly in response to platelet activation (Shiina2009The). Although the specific molecular activities and cellular locations of LY6G6F in healthy human cells are not fully detailed, it is expressed in K562 acute myeloblastic leukemia cells and is involved in filipodia functions, which are cellular protrusions that play roles in cell movement and environmental sensing (Loughner2016Organization). The expression of LY6G6F is most pronounced in blood and testis, suggesting a role in these tissues (Caruso2022Lymphocyte).

## Interactions
LY6G6F is known to interact with the proteins GRB2 and GRB7. These interactions have been identified in K562 acute myeloblastic leukemia cells, although the specific nature and functional consequences of these interactions remain unclear (Loughner2016Organization). The protein is predicted not to have a GPI-anchor, which suggests it may not be membrane-tethered like some other members of the Ly6/uPAR family (Loughner2016Organization). Despite these interactions, the cellular function of LY6G6F is currently unknown, and further research is needed to elucidate its role in cellular processes and potential involvement in signaling pathways. The gene's expression and interactions have been noted in the context of acute myeloid leukemia, but specific details about its role in this disease or other conditions have not been fully characterized (Kuang2021New). The lack of a GPI-anchor and the unknown cellular function suggest that LY6G6F might have unique properties compared to other Ly6/uPAR family members, which often participate in immune response regulation and cell signaling.


## References


[1. (Caruso2022Lymphocyte) Francesca Pia Caruso, Mario Rosario D’Andrea, Luigi Coppola, Matteo Landriscina, Valentina Condelli, Luigi Cerulo, Guido Giordano, Almudena Porras, and Massimo Pancione. Lymphocyte antigen 6g6d-mediated modulation through p38α mapk and dna methylation in colorectal cancer. Cancer Cell International, August 2022. URL: http://dx.doi.org/10.1186/s12935-022-02672-1, doi:10.1186/s12935-022-02672-1. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-022-02672-1)

[2. (Loughner2016Organization) Chelsea L. Loughner, Elspeth A. Bruford, Monica S. McAndrews, Emili E. Delp, Sudha Swamynathan, and Shivalingappa K. Swamynathan. Organization, evolution and functions of the human and mouse ly6/upar family genes. Human Genomics, April 2016. URL: http://dx.doi.org/10.1186/s40246-016-0074-2, doi:10.1186/s40246-016-0074-2. This article has 158 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-016-0074-2)

[3. (Leth2019Evolution) Julie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, Anni Kumari, Anne-Marie Lund Winther, Stephen G. Young, and Michael Ploug. Evolution and medical significance of lu domain−containing proteins. International Journal of Molecular Sciences, 20(11):2760, June 2019. URL: http://dx.doi.org/10.3390/ijms20112760, doi:10.3390/ijms20112760. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112760)

[4. (Kuang2021New) Ye Kuang, Yang Wang, Xianghong Cao, Chuanmei Peng, and Hui Gao. New prognostic factors and scoring system for patients with acute myeloid leukemia. Oncology Letters, October 2021. URL: http://dx.doi.org/10.3892/ol.2021.13084, doi:10.3892/ol.2021.13084. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.13084)

[5. (Shiina2009The) Takashi Shiina, Kazuyoshi Hosomichi, Hidetoshi Inoko, and Jerzy K Kulski. The hla genomic loci map: expression, interaction, diversity and disease. Journal of Human Genetics, 54(1):15–39, January 2009. URL: http://dx.doi.org/10.1038/jhg.2008.5, doi:10.1038/jhg.2008.5. This article has 568 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/jhg.2008.5)